Implementing a new and improved imaging protocol can significantly reduce the use of gadolinium-based contrast agents (GBCAs) when treating multiple sclerosis (MS) patients, according to a new study published in the Journal of the American College of Radiology.

AliveCor has been granted FDA clearance for KardiaMobile 6L, the world’s first publicly available six-lead personal electrocardiogram device.

Physicians are bringing in more revenue at hospitals in 2019 than previously, according to a recent report from Merritt Hawkins.

A dietary supplement commonly used to relieve osteoarthritis and joint pain may also double as a cardioprotector, Tulane University researchers reported in The BMJ May 14.

Academic and popular writings on the use of “embodied” AI in mental healthcare are piling up fast. But where’s the guidance for psychiatrists, psychotherapists and clinical social workers looking to use robots, avatars and chatbots with real patients?

The method spared nearly 90% of patients from unnecessary contrast and additional imaging sequences, reported authors of a May 16 study published in the Journal of the American College of Radiology.

Instead of Googling symptoms to when feeling an ailment and landing on an incorrect diagnosis, AI could soon provide accurate diagnosis without needing to go to a doctor’s office.

A federal judge on May 15 ruled the FDA acted illegally more than a year and a half ago when it allowed e-cigarette products geared toward kids and teens to remain on the market prior to and during the agency’s approval process.

Janesville, Wisconsin-based SHINE Medical Technologies has announced an agreement with the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), gaining exclusive rights over an innovation to produce lutetium-177 (Lu-177).

Icometrix, an international developer of AI-based brain imaging solutions, has raised $18 million in funding.